HIV Research Today is a free monthly online journal that collates and summarizes the latest research about HIV, including details on human immunodeficiency virus, testing, treatment, prevention, vaccines, aids.

Volume 2 (2005), Issue 11 (November)

1. NK cells in HIV infection: paradigm for protection or targets for ambush.
   Nat Rev Immunol, 5(11): 835-43. [Abstract] [Full-text]
2. Is early HIV testing of infants in poorly resourced prevention of mother to child transmission programmes unaffordable?
   Trop Med Int Health, 10(11): 1108-13. [Abstract] [Full-text]
3. TFII-I and USF (RBF-2) regulate Ras/MAPK-responsive HIV-1 transcription in T cells.
   Eur J Cancer, 41(16): 2528-36. [Abstract] [Full-text]
4. Dental care and HIV-infected individuals: are they equally treated?
   Community Dent Oral Epidemiol, 33(6): 447-53. [Abstract] [Full-text]
5. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.
   Nature, 438(7064): 99-102. [Abstract] [Full-text]
6. Transcription factor GATA-1 potently represses the expression of the HIV-1 coreceptor CCR5 in human T cells and dendritic cells.
   Blood, 106(10): 3440-8. [Abstract] [Full-text]
7. CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis.
   Blood, 106(10): 3524-31. [Abstract] [Full-text]
8. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection.
   Blood, 106(10): 3366-9. [Abstract] [Full-text]
9. Nephrotic range proteinuria and CD4 count as noninvasive indicators of HIV-associated nephropathy.
   Am J Med, 118(11): 1288. [Abstract] [Full-text]
10. Prevalence, incidence, and residual risk of human immunodeficiency virus among community and replacement first-time blood donors in São Paulo, Brazil.
    Transfusion, 45(11): 1709-14. [Abstract] [Full-text]
11. Surveillance technology for HIV-1 subtype C in Ethiopia: an env-based NASBA molecular beacon assay to discriminate between subcluster C and C'.
    J Virol Methods, 130(1): 22-9. [Abstract] [Full-text]
12. Direct interaction of the human I-mfa domain-containing protein, HIC, with HIV-1 Tat results in cytoplasmic sequestration and control of Tat activity.
    Proc Natl Acad Sci U S A, 102(45): 16362-7. [Abstract] [Full-text]
13. Determination of gag and env subtypes of HIV-1 detected among injecting drug users (IDUs) in Manipur, India: evidence for intersubtype recombination.
    Virus Res, 114(1): 149-53. [Abstract] [Full-text]
14. Hypertension in HIV-infected patients: prevalence and related factors.
    Am J Hypertens, 18(11): 1396-401. [Abstract] [Full-text]
15. Stabilization of white blood cells and immunologic markers for extended analysis using flow cytometry.
    J Immunol Methods, 305(2): 107-19. [Abstract] [Full-text]
16. Fetal and neonatal exposure to AZT and low-protein diet affects glucose homeostasis: a model with implications for AIDS prevention.
    Am J Physiol Endocrinol Metab, 289(6): E1115-8. [Abstract] [Full-text]
17. Does scale matter? The costs of HIV-prevention interventions for commercial sex workers in India.
    Bull World Health Organ, 83(10): 747-55. [Abstract] [Full-text]
18. Analysis of how the health systems context shapes responses to the control of human immunodeficiency virus: case-studies from the Russian Federation.
    Bull World Health Organ, 83(10): 730-8. [Abstract] [Full-text]
19. Structure of a V3-containing HIV-1 gp120 core.
    Science, 310(5750): 1025-8. [Abstract] [Full-text]
20. Knowledge, attitudes, behaviors, and perceptions of risk related to HIV/AIDS among Chinese university students in Hunan, China.
    AIDS Patient Care STDS, 19(11): 769-77. [Abstract] [Full-text]
21. Antiretroviral therapy and sexual behavior: a comparative study between antiretroviral- naive and -experienced patients at an urban HIV/AIDS care and research center in Kampala, Uganda.
    AIDS Patient Care STDS, 19(11): 760-8. [Abstract] [Full-text]
22. Effects of a treatment adherence enhancement program on health literacy, patient-provider relationships, and adherence to HAART among low-income HIV-positive Spanish-speaking Latinos.
    AIDS Patient Care STDS, 19(11): 745-59. [Abstract] [Full-text]
23. Preventing HIV among Latino and African American gay and bisexual men in a context of HIV-related stigma, discrimination, and homophobia: perspectives of providers.
    AIDS Patient Care STDS, 19(11): 737-44. [Abstract] [Full-text]
24. Incidence and impact of posttraumatic stress disorder and comorbid depression on adherence to HAART and CD4+ counts in people living with HIV.
    AIDS Patient Care STDS, 19(11): 728-36. [Abstract] [Full-text]
25. Life stress and adherence to antiretroviral therapy among HIV-positive individuals: a preliminary investigation.
    AIDS Patient Care STDS, 19(11): 719-27. [Abstract] [Full-text]
26. Deaths of HIV-positive men in the context of assisted reproduction: five case studies from a single center.
    AIDS Patient Care STDS, 19(11): 712-8. [Abstract] [Full-text]
27. Age of menopause and menopausal symptoms in HIV-infected women.
    AIDS Patient Care STDS, 19(11): 703-11. [Abstract] [Full-text]
28. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.
    J Clin Virol, 34(4): 310-4. [Abstract] [Full-text]
29. CCR2-64I and CXCL12 3'A alleles confer a favorable prognosis to AIDS patients undergoing HAART therapy.
    J Clin Virol, 34(4): 302-9. [Abstract] [Full-text]
30. Dynamics of enfuvirtide resistance in HIV-infected patients during and after long-term enfuvirtide salvage therapy.
    J Clin Virol, 34(4): 295-301. [Abstract] [Full-text]
31. Clonal analysis of HIV-1 variants in proviral DNA during treatment interruption in patients with multiple therapy failures.
    J Clin Virol, 34(4): 288-94. [Abstract] [Full-text]
32. HIV-1 drug resistance in Thailand: before and after National Access to Antiretroviral Program.
    J Clin Virol, 34(4): 272-6. [Abstract] [Full-text]
33. Comparative performance evaluation of the HIV-1 LiPA protease and reverse transcriptase resistance assay on clinical isolates.
    J Clin Virol, 34(4): 268-71. [Abstract] [Full-text]
34. Detection and quantification of proviral HIV-1 184 M/V in circulating CD4(+) T cells of patients on HAART with a viremia less than 1,000 copies/ml.
    J Clin Virol, 34(4): 257-67. [Abstract] [Full-text]
35. TaqMan RT-PCR and VERSANT HIV-1 RNA 3.0 (bDNA) assay Quantification of HIV-1 RNA viral load in breast milk.
    J Clin Virol, 34(4): 253-6. [Abstract] [Full-text]
36. Comprehensive comparison of the VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 MONITOR 1.5 assays on 1,000 clinical specimens.
    J Clin Virol, 34(4): 245-52. [Abstract] [Full-text]
37. Basics of the virology of HIV-1 and its replication.
    J Clin Virol, 34(4): 233-44. [Abstract] [Full-text]
38. Evolution of HIV resistance during treatment interruption in experienced patients and after restarting a new therapy.
    J Clin Virol, 34(4): 277-87. [Abstract] [Full-text]
39. Improved gene expression in resting macrophages using an oligopeptide derived from Vpr of human immunodeficiency virus type-1.
    Biochem Biophys Res Commun, 338(3): 1499-506. [Abstract] [Full-text]
40. HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration.
    Virology, 343(2): 256-66. [Abstract] [Full-text]
41. The R362A mutation at the C-terminus of CA inhibits packaging of human immunodeficiency virus type 1 RNA.
    Virology, 343(2): 190-200. [Abstract] [Full-text]
42. Induction of immune response in macaque monkeys infected with simian-human immunodeficiency virus having the TNF-alpha gene at an early stage of infection.
    Virology, 343(2): 151-61. [Abstract] [Full-text]
43. Evolution of human immunodeficiency virus type 2 coreceptor usage, autologous neutralization, envelope sequence and glycosylation.
    J Gen Virol, 86: 3385-96. [Abstract] [Full-text]
44. The majority of human immunodeficiency virus type 1 particles present within splenic germinal centres are produced locally.
    J Gen Virol, 86: 3369-73. [Abstract] [Full-text]
45. Introduction of HIV post-exposure prophylaxis for sexually abused children in Malawi.
    Arch Dis Child, 90(12): 1297-9. [Abstract] [Full-text]
46. Use of total lymphocyte count for informing when to start antiretroviral therapy in HIV-infected children: a meta-analysis of longitudinal data.
    Lancet, 366(9500): 1868-74. [Abstract] [Full-text]
47. Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial.
    Lancet, 366(9500): 1862-7. [Abstract] [Full-text]
48. Results of silicone oil removal in patients with cytomegalovirus retinitis related retinal detachments.
    Am J Ophthalmol, 140(5): 786-793. [Abstract] [Full-text]
49. Intravaginal practices, bacterial vaginosis, and women's susceptibility to HIV infection: epidemiological evidence and biological mechanisms.
    Lancet Infect Dis, 5(12): 786-94. [Abstract] [Full-text]
50. An inhibitor of c-Jun N-terminal kinases (CEP-11004) counteracts the anti-HIV-1 action of trichosanthin.
    Biochem Biophys Res Commun, 339(1): 25-9. [Abstract] [Full-text]

© 2004-2010 HIV Research Today. All Rights Reserved.